Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kovaltry in Chinese Patients With Severe Hemophilia A (Phase IV)
CTR20191945Phase 4Completed
- Sponsor
- ---
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of rurioctocog alfa pegol in hemophilia A, sponsored by ---. Started Aug 2020; status: completed.
02
Drugs
rurioctocog alfa pegol
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20191945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191945.